Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ANI Pharmaceuticals, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ANIP
Nasdaq
2830
www.anipharmaceuticals.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ANI Pharmaceuticals, Inc.
ImmunityBio to Report Q1 Earnings: What's in the Cards?
- May 4th, 2026 11:09 am
BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?
- May 4th, 2026 8:00 am
Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?
- May 4th, 2026 7:54 am
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy?
- May 1st, 2026 8:00 am
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- May 1st, 2026 7:00 am
ANI Pharmaceuticals (ANIP) Announces Launch of Pimozide Tablets 1 mg and 2 mg
- May 1st, 2026 1:58 am
Zacks.com featured highlights include Mirion Technologies, Intuit and ANI Pharmaceuticals
- Apr 29th, 2026 7:58 am
NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLA
- Apr 28th, 2026 11:02 am
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
- Apr 28th, 2026 7:40 am
Assessing ANI Pharmaceuticals (ANIP) Valuation After New U.S. Generic Drug Launches
- Apr 27th, 2026 5:04 pm
3 Top Stocks With Accelerating Earnings and Solid Upside Ahead
- Apr 27th, 2026 1:00 pm
Why ANI (ANIP) is Poised to Beat Earnings Estimates Again
- Apr 27th, 2026 10:10 am
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
- Apr 24th, 2026 4:50 am
KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data
- Apr 20th, 2026 8:22 am
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New Generics
- Apr 20th, 2026 8:19 am
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target?
- Apr 20th, 2026 8:18 am
ANIP's Cortrophin Gel Surge Powers 2026 Growth Outlook
- Apr 20th, 2026 8:17 am
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
- Apr 20th, 2026 4:50 am
Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
- Apr 17th, 2026 10:45 am
How Much Upside is Left in ANI (ANIP)? Wall Street Analysts Think 41.71%
- Apr 17th, 2026 7:55 am
Scroll